SCHEMBL4693546

SCHEMBL4693546

CN(C)C(=O)N1CCN(Cc2ccc(CC(=O)NCCOC(=O)N(c3ccccc3-c3ccccc3)N3CC[CH]CC3)cc2)CC1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.40
MCL1 Q07820 2/20 0.38
CHRM4 P08173 1/20 0.37
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 1/20 0.36
BACE1 P56817 1/20 0.35
FAAH O00519 2/20 0.35
BCHE P06276 1/20 0.35
ACHE P22303 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4692679 0.82 PDCD1 (0.41) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL4695739 0.82 AKR1C3 (0.40) POLBALDH1A1MEN1KMT2AGAA
SCHEMBL4694658 0.80 ALDH1A1 (0.36) MCL1ALDH1A1MEN1KMT2AMAPT
SCHEMBL2639688 0.79 POLB (0.44) POLBALDH1A1GAABCHEACHE
SCHEMBL6027362 0.79 TRPV1 (0.39) ALDH1A1LMNABCHE
SCHEMBL4691194 0.78 DRD4 (0.38) ALDH1A1MEN1KMT2AGAAMAPT
SCHEMBL4696924 0.77 CHRM2 (0.41) POLBLMNABCHEACHE
SCHEMBL4691773 0.76 KDM4E (0.41) POLBALDH1A1MEN1KMT2ALMNA
SCHEMBL4695744 0.75 HDAC1 (0.37) POLBALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL6027475 0.75 TRPV1 (0.37) POLBGAALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893577-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-03-05 EP claimed
WO-2006138218-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-12-28 WO claimed